Prudentix Ltd. Our mission is to develop advanced products that aid in regeneration and recovery after injuries or disease. Using our novel human recombinant amelogenin as an active ingredient, we have created proprietary solutions for treating orthopedic injuries, periodontitis, and other oral defects.

We started our journey by focusing on products for professional dental use, specifically chronic and acute gingivitis. Through collaboration with renowned researchers from the Hadassah Medical Center and the Hebrew University in Jerusalem, we expanded our expertise to include regenerative effects on injured joints and orthopedic ailments. We have also ventured into the dermatological field, researching new indications.

Located in a state-of-the-art facility, we collaborate with other pharmaceutical companies to enrich our knowledge and improve product characteristics. With our experienced development team and modern manufacturing plant, we can rapidly develop, scale up, and market exclusive new products to maximize convenience for our customers. Our goal is to improve the health of people worldwide by combining research, development, manufacturing, and marketing to create innovative medical devices based on advanced scientific know-how.

Contact us today to learn more about our groundbreaking solutions